The American Chamber of Commerce to the EU (AmCham EU) continues to condemn Russia’s invasion of Ukraine in the strongest possible terms. As we emphasised over a week ago, we stand with the people of Ukraine as they face incredible suffering and violence.
Ukraine invasion: AmCham EU commends unity from EU, US and partners
The American Chamber of Commerce to the EU (AmCham EU) continues to condemn Russia’s invasion of Ukraine in the strongest possible terms. As we emphasised over a week ago, we stand with the people of Ukraine as they face incredible suffering and violence.
We cannot and should not remain silent in the face of the senseless loss of human lives. Russia’s actions are threatening the fundamental values upon which our societies are based.
Business is an integral part of society and, as such, has an important role to play in difficult times. Many companies – beyond our membership only – are taking action to support the Ukrainian people and facilitate humanitarian aid. We urge the private sector to continue to step up and engage. Fellow American Chambers of Commerce across Europe and Eurasia, our sister organisations, are also doing their utmost to channel aid and support refugees, in particular in neighbouring countries.
We commend the EU, the US and many other partners for their swift reactions. The severity of the situation continues to require unity and solidarity across the Atlantic and with the international community.
We fully support the call from the International Committee of the Red Cross to uphold humanitarian law and protect civilians. All ongoing efforts to avoid further escalation and safeguard peace are critical.
Related items
:focal())
News
5 May 2026
Simplifying the Foreign Subsidies Regulation
With the Foreign Subsidies Regulation (FSR) under review, now is the moment to ensure it delivers on its objectives without creating unnecessary complexity. The FSR plays an important role in addressing distortive foreign subsidies. However, its broad scope and resource-intensive procedures risk undermining its effectiveness.
The current framework creates significant burdens for investors and contracting authorities managing public procurement processes. Changes to the Implementing Regulation alone would only provide limited value. Simplification will require targeted amendments to the primary legislation.
Read more about proposed amendments that would help refocus the FSR on high-risk cases and support the EU’s competitiveness goals.
:focal())
News
4 May 2026
Discussing financial services with policymakers in Paris and Strasbourg
From Monday, 27 to Wednesday, 29 April, AmCham EU travelled to Paris, France and the European Parliament in Strasbourg, France for a series of meetings on EU financial services policy developments. The delegation engaged with representatives from French and European financial authorities, Members of the European Parliament, Accredited Parliamentary Assistants and Group Policy Advisers, to share business perspectives on the EU’s financial services agenda. Discussions focused on how to improve Europe’s competitiveness, deepen capital markets and create the right conditions for innovation in digital finance. Members also highlighted the need for more coherent and interoperable rules that reduce complexity while encouraging long-term investment through risk-based regulation.
:focal())
News
4 May 2026
Discussing healthcare policy priorities in Strasbourg
On Tuesday, 28 to Wednesday, 29 April, AmCham EU travelled to the European Parliament in Strasbourg, France for a series of meetings with policymakers to discuss ongoing EU healthcare policy initiatives. The delegation met with Members of the European Parliament, Accredited Parliamentary Assistants and Group Policy Advisers, to discuss priorities for the EU’s health agenda. This included exchanges on how to strengthen Europe’s life sciences competitiveness and support resilient supply chains. Members also stressed the need for urgent action to simplify overlapping rules and reduce complexity. They underlined that proportionate, risk-based regulation is essential to support innovation. This approach can also help ensure timely patient access to medicines, medical technologies and diagnostics.
Policy priorities
Insights and advocacy driving Europe’s policy agenda. Our priorities support growth, innovation and a stronger transatlantic economy.
Membership
Connecting business and policymakers to strengthen the voice of American companies in Europe.